These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7779025)

  • 1. Tissue transmigration of CZON (Cosmosin) to middle ear mucosa, maxillary sinus mucosa, and palatine tonsils.
    Tsuruta Y; Hata F; Yane K; Kashiwagi N; Fujita N; Kitaoku Y; Tanaka O; Miyahara H; Matsunaga T
    Auris Nasus Larynx; 1994; 21(4):232-6. PubMed ID: 7779025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of azidocillin into the secretion and tissues in chronic maxillary sinusitis and tonsillitis.
    Jokinen K; Raunio V
    Acta Otolaryngol; 1975; 79(5-6):460-5. PubMed ID: 1174004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transport of cefotetan into the otorhinolaryngeal tissues].
    Fujimaki Y; Kawamura S; Sugita R
    Jpn J Antibiot; 1983 Jun; 36(6):1317-24. PubMed ID: 6581337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study in postoperative bile excretion of cefuzonam].
    Hirano M; Fujimura M; Yamamoto A; Yamamoto I; Nishimura K; Takahara H; Hirano T; Mori A
    Jpn J Antibiot; 1991 Jan; 44(1):9-13. PubMed ID: 2041151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on doxycycline intravenous in various infections of otorhinolaryngological field (author's transl)].
    Sambe B; Murakami H; Kobayashi K; Jo K; Inafuku S
    Jpn J Antibiot; 1975 Aug; 28(4):623-7. PubMed ID: 1160151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Level of doxycycline in the palatine tonsils in the maxillary sinus mucosa and in sinus secretions].
    Bordes R; Leluc R; Le Bourgeois M; Cudennec Y; Risgallah A
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):131-4. PubMed ID: 7355082
    [No Abstract]   [Full Text] [Related]  

  • 7. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefuzonam penetration into cerebrospinal fluid].
    Yasumoto Y; Kadota Y; Kumami K; Miyajima M; Tsuji O; Nakano H; Matsumura K
    Jpn J Antibiot; 1993 Jan; 46(1):36-43. PubMed ID: 8455330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of intraocular penetration level of cefuzonam sodium and cefotiam after intravenous and subconjunctival injection].
    Sugihara I; Ueda K; Saiki H; Hanada M; Doi H; Ishibashi T; Nakayama M; Numa R; Yamauchi K; Kawata R
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):211-8. PubMed ID: 2368649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of erythromycin stearate into maxillary sinus mucosa and secretion in chronic maxillary sinusitis.
    Paavolainen M; Kohonen A; Palva T; Renkonen OV
    Acta Otolaryngol; 1977; 84(3-4):292-5. PubMed ID: 199040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study of pulmonary tissue uptake of cefuzonam and its use in prophylaxis of postoperative infections].
    Imaizumi M; Ojika T; Uchida T; Uchida Y; Sakakibara M; Kondo D; Abe T
    Jpn J Antibiot; 1989 Nov; 42(11):2393-405. PubMed ID: 2621781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic study of bacampicillin in patients with chronic maxillary sinusitis.
    Sorri M; Jokinen K; Peltomäki E
    Infection; 1979; 7 Suppl 5():S475-7. PubMed ID: 511361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on cefuzonam concentrations in myocardium in open heart surgery].
    Higami T; Ogawa K; Asada T; Chibana M; Mukohara N; Nishiwaki M; Yoshimura N
    Jpn J Antibiot; 1989 Sep; 42(9):1882-7. PubMed ID: 2810751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cefuzonam in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Koido R; Kamigaki M; Nakada Y
    Jpn J Antibiot; 1987 Mar; 40(3):613-29. PubMed ID: 3613082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology. Study group of cefuzonam in the field of obstetrics and gynecological infections].
    Matsuda S; Suzuki M; Miyazaki R; Shimizu T; Mure K; Soma A; Hasegawa T; Haga H; Saito T; Saito S
    Jpn J Antibiot; 1988 Aug; 41(8):971-96. PubMed ID: 3050195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of lysozyme in several diseases of the otorhinolaryngeal organs].
    Brofman AV; Barulina NV
    Zh Ushn Nos Gorl Bolezn; 1976; (3):60-5. PubMed ID: 1014867
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology].
    Kubota K; Yasuhi I; Hirai M; Shimomura K
    Jpn J Antibiot; 1988 Aug; 41(8):1015-29. PubMed ID: 3050187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfer of cefuzonam into female genital organs].
    Hongo M; Shimizu R; Sakae K; Kohchi T; Tani M
    Jpn J Antibiot; 1988 Aug; 41(8):997-1001. PubMed ID: 3172470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.